Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was pioneered in Italy. The 3-5-11 schedule is now used in a growing number of European countries. Infanrix\u2122 hexa (DTPa-HBV-IPV/Hib, GlaxoSmithKline Vaccines) was first licensed for use in 2000 and has been the only pediatric hexavalent vaccine available since 2005. We reviewed available clinical trial data describing the immunogenicity of DTPa-HBV-IPV/Hib when administered at 3, 5, and 11 mo of age, and conducted an analysis of safety using global and Italian post-marketing surveillance data. In Italy, DTPa-HBV-IPV/Hib has a demonstrated safety record extending over a decade of use, it has been associated with record levels of vaccine covera...
Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vacc...
Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the Nat...
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at hi...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11\u201312 mo of age ...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was ...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Hexavalent vaccines, protecting against six diseases (diphtheria, tetanus, pertussis [DTaP], poliovi...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Liguria was the first Italian Administrative Region, since 2003, to actively recommend free-of-charg...
Hexavalent vaccines, protecting against six diseases (diphtheria, tetanus, pertussis [DTaP], poliovi...
Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vacc...
Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the Nat...
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at hi...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11\u201312 mo of age ...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was p...
Infant vaccination using 2-dose priming at 3 and 5 mo of age with a booster at 11-12 mo of age was ...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Hexavalent vaccines, protecting against six diseases (diphtheria, tetanus, pertussis [DTaP], poliovi...
Combination vaccines represent a valuable technological innovation in the field of infectious diseas...
Liguria was the first Italian Administrative Region, since 2003, to actively recommend free-of-charg...
Hexavalent vaccines, protecting against six diseases (diphtheria, tetanus, pertussis [DTaP], poliovi...
Pertussis occurs in older children, adolescents and adults due to waning immunity after primary vacc...
Hexavalent (HV) vaccination is a priority for newborn protection and in Italy is included in the Nat...
In Italy, a program of vaccination against hepatitis B targeted at the immunisation of persons at hi...